Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance

2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion



Global revenues of $3.9 billion, reflect an increase of 7% from the third quarter of 2022



Increased revenues...

Related Keywords

United States ,Ukraine ,China ,Russia ,United Kingdom ,Canada ,Brazil ,Israel ,Japan ,Israeli ,America ,R Ananthanarayanan Ananth ,Richard Francis ,Teva Pharmaceutical Industries Ltd ,Teva International ,International Markets Segment ,Our International ,International Markets Profit ,Europe Or International ,Organization For Economic ,Us Department Of Justice ,International Markets Gross Profit ,Foreign Exchange ,European Union ,Teva Pharmaceutical Industries ,North America ,Economic Co Operation ,Pillar Two ,Press Release ,International Markets ,Third Quarter ,Segment Revenues ,Major Products ,Orange Book ,Free Cash Flow ,Pharmaceutical Industries ,Private Securities Litigation Reform Act ,Quarterly Report ,Annual Report ,Looking Statements ,Markets ,